Full weight-Based chemo doses recommended for obese

Full weight-Based chemo doses recommended for obese

(HealthDay) -- The American Society of Clinical Oncology Clinical Practice Guideline on Appropriate Chemotherapy Dosing for Obese Adult Patients With Cancer recommends using full weight-based cytotoxic chemotherapy doses to treat obese patients with cancer, according to an overview published online April 2 in the Journal of Clinical Oncology.

Jennifer J. Griggs, M.D., M.P.H., of the University of Michigan in Ann Arbor, and colleagues present a summary overview of the complete new guidelines. These recommendations, which do not address dosing of novel targeted agents, were developed by a panel of experts in medical and gynecologic oncology, , pharmacokinetics and pharmacogenetics, and biostatistics, after reviewing results from a systematic review of literature published between 1996 and 2010.

The researchers primarily identified studies relating to breast, ovarian, colon, and lung cancer. They note that up to 40 percent of obese patients receive limited chemotherapy doses, which are not based on their actual body weight. For obese patients, concerns about toxicity and overdosing when the dose is based on actual body weight appear to be unfounded.

"The Panel recommends that full weight-based cytotoxic chemotherapy doses be used to treat obese patients with cancer, particularly when the goal of treatment is cure. There is no evidence that short- or long-term toxicity is increased among obese patients receiving full weight-based doses," the authors write. "Clinicians should respond to all treatment-related toxicities in in the same ways they do for non-obese patients."

More information: Abstract
Full Text

add to favorites email to friend print save as pdf

Related Stories

Minimizing obesity's impact on ovarian cancer survival

Dec 29, 2008

Obesity affects health in several ways, but new research shows obesity can have minimal impact on ovarian cancer survival. A study by researchers at the University of Alabama at Birmingham (UAB) Comprehensive Cancer Center ...

Breast cancer more aggressive among obese women

Mar 14, 2008

Women with breast cancer have more aggressive disease and lower survival rates if they are overweight or obese, according to findings published in the March 15 issue of Clinical Cancer Research, a journal of the American Associ ...

Recommended for you

Pepper and halt: Spicy chemical may inhibit gut tumors

1 hour ago

Researchers at the University of California, San Diego School of Medicine report that dietary capsaicin – the active ingredient in chili peppers – produces chronic activation of a receptor on cells lining ...

Expressive writing may help breast cancer survivors

3 hours ago

Writing down fears, emotions and the benefits of a cancer diagnosis may improve health outcomes for Asian-American breast cancer survivors, according to a study conducted by a researcher at the University of Houston (UH).

Taking the guesswork out of cancer therapy

9 hours ago

Researchers and doctors at the Institute of Bioengineering and Nanotechnology (IBN), Singapore General Hospital (SGH) and National Cancer Centre Singapore (NCCS) have co-developed the first molecular test ...

Brain tumour cells found circulating in blood

10 hours ago

(Medical Xpress)—German scientists have discovered rogue brain tumour cells in patient blood samples, challenging the idea that this type of cancer doesn't generally spread beyond the brain.

International charge on new radiation treatment for cancer

10 hours ago

(Medical Xpress)—Imagine a targeted radiation therapy for cancer that could pinpoint and blast away tumors more effectively than traditional methods, with fewer side effects and less damage to surrounding tissues and organs.

User comments